The pathology technology sector has moved incredibly quickly to develop, manufacture and supply testing devices for detecting COVID-19 infections and identifying the SARS-CoV-2 virus. Within 8 weeks of the virus becoming a significant human threat, the first commercial tests were available to detect COVID-19 infection in humans. The pathology technology suppliers are a key part of a broader ecosystem that includes the pathologist, scientists, lab staff and sample collection teams in hospital and commercial labs. It includes the community medical services where point of care testing is conducted. Of key importance in the COVID-19 example are research scientists at medical research institutes such as the Peter Doherty Centre. It is in centers like these that the basic research is completed which is often the initiator for production of commercial test products.The technology provided by Pathology Technology Australia members is critical to these research center, for without it, none of their valuable work can be done. This page aims to provide up to date information on health testing in the COVID-19 pandemic. We will cover many facets of the pathology technology so vital to testing human health in laboratories, hospitals, medical clinics and at home.


COVID-19 UPDATES

Dean Whiting on SBS News PTA was recently interview by SBS World News on testing. Head to 2.45 on clip to see CEO Dean Whiting discussing testing strategies

TGA EXEMPTIONS  We have been successful in getting the law changed; so that our companies can import and supply COVID-19 tests under the TGA exemption. I know that some of you have been concerned about the wording of the original exemption. Some of you have decided to go down the full registration route. All good, and in the end, everyone will need full registration (if you plan to keep selling after 31 Jan 2021). See this link for details.




COVIDeocasts 

TESTING FOR COVID-19

TYPES OF TESTING 

DESIGN AND PRODUCTION OF TESTS

TRUSTING YOUR PATHOLOGY TECHNOLOGY PROVIDER

CONTINUITY OF CARE - AVOIDING THE 2nd TSUNAMI 

ANTIBODY TESTING 

PCR TESTING 


TESTING STRATEGY 

ASSESING COVID-19 SEROLOGY TESTS


INTERVIEW WITH PROF BILL RAWLINSON


DETAILS FOR TRAVEL WITHIN STATES 

Summary of Border Controls and Exemptions.pdf

Contacts within states 

COVID-19 GLOBAL TRACKER



  • 27 Mar 2020 4:44 PM | Anonymous member (Administrator)

    PTA has joined with MTAA in seeking ACCC exemption from certain trade practices laws in the event that companies need to share supply information in the fight against COVID-19. ACCC has given interim authorisation for this exemption.

    My very strong recommendation is that all companies continue to observe all trade practices and business compliance laws until specifically requested otherwise. If your company is still a concern, please seek your own legal opinion.

    This link contains the ACCC interim authorisation. It lists the companies covered.

    I extend my thanks to Ian Burgess, CEO of MTAA, for including us in this opportunity.



  • 26 Mar 2020 4:43 PM | Anonymous member (Administrator)

    Many member companies are being approached by media for comments and input about aspects of COVID-19. I know many companies have internal protocols for managing approaches by media. However, it may not always be obvious that you are inadvertently contributing to a news story. Our Associate Member London Agency has kindly offered to run a free webinar on Media Awareness. Please see the link to John Emmerson’s video about this topic. Details of the webinar will be on our website shortly.




Powered by Wild Apricot Membership Software